Diagnostic Nanotools develops new diagnostic tools. In 2022, we worked in the context of projects DTS20/00093 and LCF/TR/CC21/52490005 Consolidate, funded by ISCIII and La Caixa, to develop a synthetic reagent to replace erythrocytes in classical haemagglutination assays used worldwide to track flu epidemics. This product detects several influenza virus types and can be mass produced for global distribution. Over 2023, we will transfer this technology to a company. Besides, we worked in the context of project AC21_2/00021 QUPID EuroNanoMed to produce point-of-care diagnostic devices for fast, simple and quantitative detection of malaria. Among others, we showed that assay automation using paper devices provides efficient biomarker detection with little user intervention. Finally, in project PID2020-118904RB-C22 RETOS, in collaboration with researchers at the National Microelectronics Centre, we are developing a device for digital ultrasensitive detection of respiratory infections.

Group Leader
Eva Baldrich Rubio

Researchers
Briza Pérez López

PhD Students
Ana Sánchez Cano, Kevin Ricardo Arias Alpizar

Lab Technicians
Erica de la Serna Botello, Judit Prat Trunas, Maria Urpí Castany

2

PUBLICATIONS

100.0%

%Q1

18

IMPACT FACTOR

9.14

AVERAGE IMPACT FACTOR

SELECTED ARTICLES

K Arias-Alpízar, A Sánchez-Cano, J Prat-Trunas, E Sulleiro, P Bosch-Nicolau, F Salvador, I Oliveira, I Molina, A Sánchez-Montalvá, E Baldrich
Magnetic bead handling using a paper-based device for quantitative point-of-care testing
Biosensors, 2022, 12, 680
DOI: doi: 10.3390/bios12090680
IF: 5.743

K Arias-Alpízar, A Sánchez-Cano, J Prat-Trunas, E de la Serna. O Alonso, E Sulleiro, A Sánchez-Montalvá, A Diéguez, E Baldrich
Malaria quantitative POC testing using magnetic particles, a paper microfluidic device and a hand-held fluorescence reader
Biosens Bioelectron, 2022, 215, 114513
DOI: doi: 10.1016/j.bios.2022.114513
IF: 12.545

Synthetic Erythrocytes for the Surveillance of Infectious Diseases (LCF/TR/CC21/52490005)
Principal Investigator: Eva Baldrich
Agency: La Caixa Foundation, Proyectos Consolidate
Funding: 238,920 €
Period: 2022-2024

Quantitative and storage-stable point-of-care diagnostic device (QUPID; AC21_2/00021)
Principal Investigator: Eva Baldrich
Agency: Instituto de Salud Carlos III - Unión Europea (FEDER/FSE). 12th Joint Transnational Call for Proposals for
Funding: 214,333.35 €
Period: 2022-2024

Desarrollo de tests rápidos y ultrasensibles para infecciones respiratorias (PID2020-118904RB-C22)
Principal Investigator: Eva Baldrich
Agency: Ministerio de Ciencia e Innovación – Convocatoria Proyectos de I+D+i Orientada a los Retos de la Sociedad
Funding: 73,810 €
Period: 2021-2024

Dispositivo diagnóstico sintético como sustituto de los eritrocitos animales en los ensayos de hemaglutinación clásicos: aplicación a la vigilancia de los virus de la gripe (DTS20/00093)
Principal Investigator: Eva Baldrich
Agency: Instituto de Salud Carlos III – Convocatoria de Proyectos de Desarrollo Tecnológico en Salud
Funding: 104,500 €
Period: 2021-2023

Eritrocits sintètics per a la vigilància del virus de la grip (SIFECAT: IU68-017255 / número expedient: 2019PROD00086)
Principal Investigator: Eva Baldrich
Agency: Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), Departament d'Empresa i Coneixement, Generalitat de Catalunya. Projectes Producte
Funding: 100,000 €
Period: 2020-2022

Reagents and fast methods for pathogen characterization and serology testing
Priority Number: PCT/EP2020/066292
Priority Date: 12/06/2020
Applicants: 100% VHIR

eCOREs